ANVS
Annovis Bio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.52
+0.06 ▲ +2.44%
🌙 3월 13일 7:53 PM ET (한국 3/14 08:53)
$2.44
-0.08 ▼ -3.17%
| Index | - | P/E | - | EPS (ttm) | -1.4 | Insider Own | 15.45% | Shs Outstand | 0.03B | Perf Week | 1.2% |
| Market Cap | 0.07B | Forward P/E | - | EPS next Y | 0.22% | Insider Trans | 41.08% | Shs Float | 0.02B | Perf Month | 6.33% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | -0.31 | Inst Own | 19.88% | Short Float | 12.25% | Perf Quarter | -40% |
| Income | -0.03B | P/S | - | EPS this Y | 43.52% | Inst Trans | 17.78% | Short Ratio | 6.26 | Perf Half Y | 5.44% |
| Sales | 0.00B | P/B | 4.07 | EPS next 5Y | 18.51% | ROA | -164.85% | Short Interest | 2.75M | Perf YTD | -27.17% |
| Book/sh | 0.62 | P/C | 3.42 | EPS past 3/5Y | 23.23% -10.15% | ROE | -220.61% | 52W High | -54.18% ($5.50) | Perf Year | 52.73% |
| Cash/sh | 0.74 | P/FCF | - | Sales past 3/5Y | - | ROIC | -171.23% | 52W Low | 127.03% ($1.11) | Perf 3Y | -83.46% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 62.84% | Gross Margin | - | Volatility(W/M) | 6.68% 7.76% | Perf 5Y | -91.41% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.2 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.8 | EPS Q/Q | 17.04% | Profit Margin | - | RSI (14) | 45.24 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.8 | Sales Q/Q | - | SMA20 | -1.22% ($2.55) | Beta | 1.32 | Target Price | $12.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -11.22% ($2.84) | Rel Volume | 0.54 | Prev Close | $2.46 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 1.78% - | SMA200 | -8.76% ($2.76) | Avg Volume(3M) | 0.44M | Price | $2.52 |
| IPO | 2020/1/29 | Option/Short | Yes/Yes | Trades | 1164 | Volume | 236,986 | Change | 2.44% |
뉴스 로딩 중...